Recommendations on the EU Commission’s White Paper on AI
In this paper, a multi-disciplinary group of Stanford students and contributors led by HAI Policy Fellow Marietje Schaake share policy recommendations with the EU Commission regarding a European approach to regulating AI, as laid out in its White Paper on AI.
Executive Summary
In our response to the White Paper “On Artificial Intelligence – A European approach to excellence and trust,” we sought to reflect on overarching themes and gaps illuminated by the white paper, to bring attention to potential second and third order effects and guide policymakers toward concrete steps to take in the months and years ahead. As a multidisciplinary group of academics, military members, technical and policy wonks, we had a diverse group of expertise contributing to each of the sections below. We begin with a focus on risk and governance for AI in a broad sense, pivot to the known unknowns related to jobs and the AI-enabled economy, and end by outlining a few items categorized as unknown unknowns for the future of AI in the EU. Below is a table preceding our analysis, highlighting the specific recommendations as they appear throughout each section. We hope these reflections and recommendations help to bolster the EU’s initiatives on artificial intelligence.
Related Publications
Response to OSTP's Request for Information on Accelerating the American Scientific Enterprise
Stanford scholars respond to a federal RFI on scientific discovery, calling for the government to support a new “team science” academic research model for AI-enabled discovery.
Stanford scholars respond to a federal RFI on scientific discovery, calling for the government to support a new “team science” academic research model for AI-enabled discovery.
Response to FDA's Request for Comment on AI-Enabled Medical Devices
Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.
Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.
Russ Altman’s Testimony Before the U.S. Senate Committee on Health, Education, Labor, and Pensions
In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.
In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.
Michelle M. Mello's Testimony Before the U.S. House Committee on Energy and Commerce Health Subcommittee
In this testimony presented to the U.S. House Committee on Energy and Commerce’s Subcommittee on Health hearing titled “Examining Opportunities to Advance American Health Care through the Use of Artificial Intelligence Technologies,” Michelle M. Mello calls for policy changes that will promote effective integration of AI tools into healthcare by strengthening trust.
In this testimony presented to the U.S. House Committee on Energy and Commerce’s Subcommittee on Health hearing titled “Examining Opportunities to Advance American Health Care through the Use of Artificial Intelligence Technologies,” Michelle M. Mello calls for policy changes that will promote effective integration of AI tools into healthcare by strengthening trust.